Impact of 5- and 6-Fr Sheaths on Hemostasis Duration and Access Site Complications in Distal Transradial Approach
Catheterization and Cardiovascular Interventions, cilt.106, sa.6, ss.3212-3218, 2025 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 106 Sayı: 6
- Basım Tarihi: 2025
- Doi Numarası: 10.1002/ccd.70187
- Dergi Adı: Catheterization and Cardiovascular Interventions
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, EMBASE, MEDLINE
- Sayfa Sayıları: ss.3212-3218
- Anahtar Kelimeler: coronary angiography, distal transradial approach, hemostasis, percutaneous coronary intervention, sheath size, vascular complications
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Background: The distal transradial approach (dTRA) is increasingly preferred for coronary angiography (CAG) and/or percutaneous coronary intervention (PCI) because of its advantages in patient comfort and vascular access. However, the effect of sheath size on these outcomes remains unclear. Aim: To compare the effects of 5-French (Fr) and 6-Fr sheaths in dTRA on vascular complications, hemostasis duration, and patient comfort. Methods: A retrospective analysis was conducted on patients who underwent dTRA for CAG between January 2020 and October 2023. Participants were categorized into two groups based on sheath size (5- vs. 6-Fr). Data on procedural details, complications, hemostasis duration, and patient discomfort were collected. Result: A total of 228 patients were included, with 72 in the 5-Fr group and 156 in the 6-Fr group. The study found no significant difference in vascular complications between the two groups (p = 0.18). However, hemostasis duration was significantly shorter in the 5-Fr group compared to the 6-Fr group (97.8 ± 27.6 vs. 122.0 ± 24.9 min; p < 0.001). Severe pain was more frequent in the 6-Fr group (p = 0.036). Regression analysis showed that severe pain, puncture time, and the use of P2Y12 receptor antagonists (P2Y12 inhibitors) were significantly associated with vascular complications (p < 0.05). Conclusion: In our study, sheath size—specifically the comparison between 5- and 6-Fr—did not significantly affect vascular complications in the dTRA. However, using a 5-Fr sheath may reduce hemostasis time and patient discomfort compared to a 6-Fr sheath. Procedural factors such as puncture time and severe pain, as well as P2Y12 inhibitor use, should be carefully considered to minimize complications. These findings support the safe application of the dTRA with sheath size tailored to individual patient characteristics.